Literature DB >> 20976998

[Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma].

A Scherpereel1, P Astoul, P Baas, T Berghmans, H Clayson, P de Vuyst, H Dienemann, F Galateau-Salle, C Hennequin, G Hillerdal, C Le Pe'choux, L Mutti, J-C Pairon, R Stahel, P van Houtte, J van Meerbeeck, D Waller, W Weder.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20976998      PMCID： PMC6134413          DOI： 10.3779/j.issn.1009-3419.2010.10.14

Source DB:  PubMed          Journal:  Zhongguo Fei Ai Za Zhi        ISSN： 1009-3419


× No keyword cloud information.
  88 in total

1.  Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.

Authors:  J C WAGNER; C A SLEGGS; P MARCHAND
Journal:  Br J Ind Med       Date:  1960-10

2.  Deterioration in lung function following hemithorax irradiation for pleural mesothelioma.

Authors:  P Maasilta
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-03       Impact factor: 7.038

3.  Guidelines for mineral fibre analyses in biological samples: report of the ERS Working Group. European Respiratory Society.

Authors:  P De Vuyst; A Karjalainen; P Dumortier; J C Pairon; E Monsó; P Brochard; H Teschler; A Tossavainen; A Gibbs
Journal:  Eur Respir J       Date:  1998-06       Impact factor: 16.671

4.  Guidelines of the French Speaking Society for Chest Medicine for management of malignant pleural mesothelioma.

Authors:  Arnaud Scherpereel
Journal:  Respir Med       Date:  2006-11-29       Impact factor: 3.415

5.  Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey.

Authors:  A Umran Dogan; Y Izzettin Baris; Meral Dogan; Salih Emri; Ian Steele; Amira G Elmishad; Michele Carbone
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

Review 6.  Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.

Authors:  Zhen J Wang; Gautham P Reddy; Michael B Gotway; Charles B Higgins; David M Jablons; Mohan Ramaswamy; Randall A Hawkins; W Richard Webb
Journal:  Radiographics       Date:  2004 Jan-Feb       Impact factor: 5.333

7.  Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).

Authors:  Gianpiero Fasola; Ornella Belvedere; Marianna Aita; Tina Zanin; Alessandro Follador; Paolo Cassetti; Stefano Meduri; Vincenzo De Pangher; Giusto Pignata; Valentina Rosolen; Fabio Barbone; Francesco Grossi
Journal:  Oncologist       Date:  2007-10

8.  Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy.

Authors:  C Boutin; F Rey; J R Viallat
Journal:  Chest       Date:  1995-09       Impact factor: 9.410

9.  Long-term results of intrathoracic chemohyperthermia (ITCH) for the treatment of pleural malignancies.

Authors:  O Monneuse; A C Beaujard; B Guibert; F N Gilly; P Mulsant; P Y Carry; M Benoit; O Glehen
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

10.  The Mesothelioma epidemic in Western Europe: an update.

Authors:  C Pelucchi; M Malvezzi; C La Vecchia; F Levi; A Decarli; E Negri
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640
View more
  5 in total

Review 1.  Extrapleural pneumonectomy: still indicated?

Authors:  Andreas Domen; Lawek Berzenji; Jeroen M H Hendriks; Suresh Krishan Yogeswaran; Patrick Lauwers; Jan P Van Meerbeeck; Paul E Van Schil
Journal:  Transl Lung Cancer Res       Date:  2018-10

Review 2.  Surgery for malignant pleural mesothelioma: an international guidelines review.

Authors:  Sara Ricciardi; Giuseppe Cardillo; Carmelina Cristina Zirafa; Francesco Carleo; Francesco Facciolo; Gabriella Fontanini; Luciano Mutti; Franca Melfi
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

3.  A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial.

Authors:  Robert A Belderbos; Paul Baas; Rossana Berardi; Robin Cornelissen; Dean A Fennell; Jan P van Meerbeeck; Arnaud Scherpereel; Heleen Vroman; Joachim G J V Aerts
Journal:  Transl Lung Cancer Res       Date:  2019-06

4.  Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention.

Authors:  N Bayman; D Ardron; L Ashcroft; D R Baldwin; R Booton; L Darlison; J G Edwards; L Lang-Lazdunski; J F Lester; M Peake; R C Rintoul; M Snee; P Taylor; C Lunt; C Faivre-Finn
Journal:  BMJ Open       Date:  2016-01-27       Impact factor: 2.692

5.  A Case of Pulmonary Embolism with Sarcomatoid Malignant Pleural Mesothelioma with Long-Term Pleural Effusion.

Authors:  Rumeng Gu; Luxi Jiang; Ting Duan; Chun Chen; Shengchang Wu; Deguang Mu
Journal:  Onco Targets Ther       Date:  2021-07-16       Impact factor: 4.147
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.